PMID- 40362636
OWN - NLM
STAT- MEDLINE
DCOM- 20250514
LR  - 20250530
IS  - 1422-0067 (Electronic)
IS  - 1422-0067 (Linking)
VI  - 26
IP  - 9
DP  - 2025 May 6
TI  - Potential Pathogenetic Role of the D313Y Mutation in the GLA Gene in Anderson 
      Fabry Disease: Two Case Reports.
LID - 10.3390/ijms26094400 [doi]
LID - 4400
AB  - Anderson Fabry disease (AFD) is an X-linked hereditary lysosomal abnormality that 
      causes the accumulation of glycosphingolipids in body fluids and tissues, leading 
      to progressive organ damage and a shortened life span. More than 1000 mutations 
      in the GLA gene have been identified, promoting many different clinical pictures. 
      For this reason, diagnosing AFD can be difficult, especially because of the great 
      diversity of atypical clinical presentations that can simulate the disease. Some 
      of these variants of the GLA gene have been described as non-pathogenic. For 
      example, the D313Y variant is one of the most controversial, even if there are 
      several case reports of D313Y patients presenting with signs and symptoms 
      consistent with AFD without any other etiological explanation. This work aimed to 
      clarify whether the presence of the D313Y variant affects Î±-Gal A activity and 
      causes AFD symptoms and organ involvement in two patients from different 
      families. The presence of the D313Y variant resulted in clinical manifestations 
      of AFD in both patients and a decrease in alpha-galactosidase activity in the 
      male patient. Two patients (one female and one male) from two unrelated families 
      were examined. Sequencing of all seven GLA exons and the adjacent 5' and 3' 
      exon-intron boundaries identified the D313Y variant in exon 6, as well as the 
      genetic variation g.1170C>T in the flanking 5' UTR in patient 1 only. Our results 
      suggest that the D313Y variant is causative for the disease and that the clinical 
      phenotype can be enhanced by the presence of other variants modulating protein 
      expression.
FAU - La Russa, Antonella
AU  - La Russa A
AD  - Nephrology Unit, Department of Health Sciences, "Magna Graecia" University, 
      I-88100 Catanzaro, Italy.
FAU - Siniscalchi, Antonio
AU  - Siniscalchi A
AUID- ORCID: 0000-0001-5360-9926
AD  - Department of Neurology and Stroke Unit, Annunziata Hospital, I-87100 Cosenza, 
      Italy.
FAU - Bonaventura, Ardito
AU  - Bonaventura A
AD  - Department of Neurology and Stroke Unit, Della Murgia Fabio Perinei Hospital, 
      I-70022 Altamura, Italy.
FAU - Di Noia, Domenico
AU  - Di Noia D
AD  - Department of Neurology and Stroke Unit, Della Murgia Fabio Perinei Hospital, 
      I-70022 Altamura, Italy.
FAU - Valsania, Teresa
AU  - Valsania T
AD  - Department of Nephrology and Dialysis, ASL "Guglielmo da Saliceto" Hospital 
      Piacenza, I-29121 Piacenza, Italy.
FAU - Stallone, Giovanni
AU  - Stallone G
AD  - Nephrology Dialysis and Transplantation Unit, Advance Research Center on Kidney 
      Aging (A.R.cK.A.), Department of Medical and Surgical Sciences, University of 
      Foggia, I-71100 Foggia, Italy.
FAU - Tartaglia, Luciano
AU  - Tartaglia L
AD  - Nephrology Dialysis and Transplantation Unit, Advance Research Center on Kidney 
      Aging (A.R.cK.A.), Department of Medical and Surgical Sciences, University of 
      Foggia, I-71100 Foggia, Italy.
FAU - Chiapparino, Concetta
AU  - Chiapparino C
AD  - Department of Neurology and Stroke Unit, Della Murgia Fabio Perinei Hospital, 
      I-70022 Altamura, Italy.
FAU - Di Rienzo, Giovanni
AU  - Di Rienzo G
AD  - U.O.S.V.D. Patologia Clinica, Ospedale Della Murgia Fabio Perinei, I-70022 
      Altamura, Italy.
FAU - Coppolino, Giuseppe
AU  - Coppolino G
AUID- ORCID: 0000-0001-8000-0681
AD  - Nephrology Unit, Department of Health Sciences, "Magna Graecia" University, 
      I-88100 Catanzaro, Italy.
FAU - Bolignano, Davide
AU  - Bolignano D
AUID- ORCID: 0000-0003-3032-245X
AD  - Department of Medical and Surgical Sciences, "Magna Graecia" University, I-88100 
      Catanzaro, Italy.
FAU - Faga, Teresa
AU  - Faga T
AD  - Renal Unit, Campus "S. Venuta", "Renato Dulbecco" University Hospital, I-88100 
      Catanzaro, Italy.
FAU - Michael, Ashour
AU  - Michael A
AD  - Nephrology Unit, Department of Health Sciences, "Magna Graecia" University, 
      I-88100 Catanzaro, Italy.
FAU - Montesanto, Alberto
AU  - Montesanto A
AUID- ORCID: 0000-0002-9563-2216
AD  - Department of Biology, Ecology and Earth Sciences, University of Calabria, 
      I-87036 Rende, Italy.
FAU - Serra, Raffaele
AU  - Serra R
AUID- ORCID: 0000-0003-4477-7412
AD  - Department of Medical and Surgical Sciences, "Magna Graecia" University, I-88100 
      Catanzaro, Italy.
FAU - Andreucci, Michele
AU  - Andreucci M
AUID- ORCID: 0000-0002-7974-3792
AD  - Nephrology Unit, Department of Health Sciences, "Magna Graecia" University, 
      I-88100 Catanzaro, Italy.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20250506
PL  - Switzerland
TA  - Int J Mol Sci
JT  - International journal of molecular sciences
JID - 101092791
RN  - EC 3.2.1.22 (alpha-Galactosidase)
RN  - EC 3.2.1.22 (GLA protein, human)
SB  - IM
MH  - Female
MH  - Humans
MH  - Male
MH  - *alpha-Galactosidase/genetics/metabolism
MH  - Exons
MH  - *Fabry Disease/genetics/pathology/diagnosis
MH  - *Mutation
MH  - Pedigree
PMC - PMC12072610
OTO - NOTNLM
OT  - D313Y
OT  - Fabry disease
OT  - GLA
OT  - VUS
OT  - mutation
OT  - polymorphisms
COIS- The authors declare no conflicts of interest.
EDAT- 2025/05/14 11:42
MHDA- 2025/05/14 11:43
PMCR- 2025/05/06
CRDT- 2025/05/14 01:12
PHST- 2025/03/25 00:00 [received]
PHST- 2025/04/24 00:00 [revised]
PHST- 2025/05/03 00:00 [accepted]
PHST- 2025/05/14 11:43 [medline]
PHST- 2025/05/14 11:42 [pubmed]
PHST- 2025/05/14 01:12 [entrez]
PHST- 2025/05/06 00:00 [pmc-release]
AID - ijms26094400 [pii]
AID - ijms-26-04400 [pii]
AID - 10.3390/ijms26094400 [doi]
PST - epublish
SO  - Int J Mol Sci. 2025 May 6;26(9):4400. doi: 10.3390/ijms26094400.
